Southern African Journal of HIV Medicine

Papers
(The TQCC of Southern African Journal of HIV Medicine is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Weight gain in children from birth to 10 years on antiretroviral treatment18
Late-onset efavirenz toxicity: A descriptive study from Pretoria, South Africa17
A multidisciplinary approach for people with HIV failing antiretroviral therapy in South Africa17
Retrospective review of maternal HIV viral load electronic gatekeeping codes in South Africa16
The 96-week outcomes and pharmacokinetics of long-acting cabotegravir plus rilpivirine in South Africans13
Hepatitis B seroprevalence among HIV-positive adults in the Free State, South Africa12
Rural nurses’ antiretroviral prescribing practices in children, Limpopo province, South Africa12
Management of drug-induced liver injury in people with HIV treated for tuberculosis: 2024 update11
Confronting the human papillomavirus–HIV intersection: Cervical cytology implications for Kenyan women living with HIV11
Social support experiences of adolescents living with perinatal HIV in rural Limpopo, South Africa9
COVID-19 and HIV viral load suppression in children and adolescents in Durban, South Africa9
Doxycycline post-exposure prophylaxis for sexually transmitted infections in South Africa9
Cutaneous squamous cell carcinoma in vertically acquired HIV and epidermodysplasia verruciformis9
Cardiovascular risk profiles in people living with HIV taking antiretroviral therapy in rural Lesotho: Findings from the PRECARIF study9
Using creativity and the arts to promote mental health in youth living with HIV in South Africa8
Acknowledgement to reviewers8
Rifampicin resistance and mortality in patients hospitalised with HIV-associated tuberculosis8
The sexual and reproductive health needs of young people living with HIV in Gauteng, South Africa8
Effect of dolutegravir on ferritin, iron, and C-reactive protein among people living with HIV and co-infections7
Tracking viral control in adolescents on antiretroviral therapy in Lusaka, Zambia: A retrospective cohort analysis7
COVID-19 severity and in-hospital mortality in an area with high HIV prevalence7
High paediatric HIV viral load rejection rate in South Africa, a retrospective review6
Radiological predictors of PCP in HIV-positive adults in South Africa: A matched case-control study6
Interpersonal relations of pregnant women post-HIV diagnosis in Thembisile Hani, South Africa6
Effect of a ward-based outreach team and adherence game on retention and viral load suppression6
Identifying sexual behavioural choices when commencing pre-exposure prophylaxis: Findings from a public health facility in eThekwini, KwaZulu-Natal, South Africa6
Pharmacokinetics, pharmacogenetics, and toxicity of co-administered efavirenz and isoniazid6
Transition of adolescents from paediatric to adult HIV care in South Africa: A policy review5
Steatotic liver disease in people with HIV at Tshepong Hospital: A post-mortem analysis5
Acceptability and performance of dual HIV/syphilis testing in male circumcision clients, 20215
Table of Contents Vol 24, No 1 (2023)5
South African harm reduction guideline for chemsex5
HIV-associated Kaposi sarcoma: Advanced disease and high mortality of patients referred to a multidisciplinary clinic in South Africa, 2022–20245
The prevalence of multimorbidity in virally suppressed HIV-positive patients in Limpopo5
Corrigendum: Unlocking insights into HIV care: An in-depth analysis of key populations from the Fast-Track Cities Quality of Care survey in eThekwini, KwaZulu-Natal, South Africa5
Causes of death in adults living with HIV in South Africa: A single-centre postmortem study5
Virologic outcomes with tenofovir-lamivudine-dolutegravir in adults failing PI-based second-line ART4
Southern African HIV Clinicians Society 2022 guideline for the management of sexually transmitted infections: Moving towards best practice4
Dolutegravir for second-line treatment: Programmatic implications of new evidence4
Thrombotic thrombocytopaenic purpura in the era of HIV: A single-centre experience4
A cross-sectional study of viral load suppression among youth living with HIV in Namibia4
HIV viral suppression after enhanced adherence counselling in children on dolutegravir-based regimens in Malawi4
Oral pre-exposure prophylaxis uptake, adherence, and adverse events among South African men who have sex with men and transgender women4
Stakeholders’ perspective on inclusion of key populations unique identifier codes in routine health information management system in South Africa4
0.03387188911438